Biotechnology SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Reata Pharmaceuticals, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of December 14, 2020 – RETA October 22, 2020
Biotechnology ROSEN, RECOGNIZED INVESTOR COUNSEL, Announces Filing of Securities Class Action Lawsuit Against Reata Pharmaceuticals, Inc.; Encourages Investors with Losses in Excess of $100K to Contact Firm – RETA October 22, 2020
Biotechnology Alkermes to Host Conference Call to Discuss Third Quarter 2020 Financial Results October 22, 2020
Biotechnology Agios Pharmaceuticals (AGIO) May Report Negative Earnings: Know the Trend Ahead of Q3 Release October 22, 2020
Biotechnology Alnylam Pharmaceuticals (ALNY) Expected to Beat Earnings Estimates: Should You Buy? October 22, 2020
Biotechnology Will Bluebird Bio (BLUE) Report Negative Q3 Earnings? What You Should Know October 22, 2020
Biotechnology Alexion Pharmaceuticals (ALXN) Expected to Beat Earnings Estimates: Should You Buy? October 22, 2020
Biotechnology DEADLINE ALERT for GLNG, GTX, GTXMQ, and BMRN: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders October 22, 2020